Goldman Sachs’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Sell |
101,888
-19,009
|
|
||||
|
2025
Q1 | $318K | Sell |
120,897
-288,563
|
|
||||
|
2024
Q4 | $1.45M | Buy |
409,460
+334,691
|
|
||||
|
2024
Q3 | $341K | Buy |
74,769
+40,298
|
|
||||
|
2024
Q2 | $150K | Buy |
34,471
+6,122
|
|
||||
|
2024
Q1 | $142K | Sell |
28,349
-16,847
|
|
||||
|
2023
Q4 | $283K | Buy |
45,196
+24,302
|
|
||||
|
2023
Q3 | $149K | Buy |
+20,894
|
|
||||
|
2023
Q2 | – | Sell |
-109,132
|
|
||||
|
2023
Q1 | $990K | Buy |
109,132
+82,777
|
|
||||
|
2022
Q4 | $189K | Buy |
+26,355
|
|
||||
|
2021
Q3 | – | Sell |
-115,264
|
|
||||
|
2021
Q2 | $704K | Sell |
115,264
-533,506
|
|
||||
|
2021
Q1 | $4.31M | Buy |
648,770
+609,002
|
|
||||
|
2020
Q4 | $210K | Buy |
39,768
+4,274
|
|
||||
|
2020
Q3 | $264K | Buy |
35,494
+16,482
|
|
||||
|
2020
Q2 | $140K | Buy |
19,012
+1,864
|
|
||||
|
2020
Q1 | $127K | Buy |
+17,148
|
|
||||
|
2018
Q4 | – | Sell |
-10,737
|
|
||||
|
2018
Q3 | $63K | Sell |
10,737
-29,550
|
|
||||
|
2018
Q2 | $228K | Buy |
40,287
+9,201
|
|
||||
|
2018
Q1 | $385K | Sell |
31,086
-22,946
|
|
||||
|
2017
Q4 | $653K | Buy |
+54,032
|
|